Novartis AG v. Glenmark Pharmaceuticals Ltd.
1:14-cv-00771
Overview
Case Number
1:14-cv-00771
Filing Date
2014-06-18
Status
Terminated
Termination Date
2015-05-26
Court
District Court, D. Delaware (ded)
Presiding Judge
Leonard P. Stark
Nature of Suit
830 Patent
Jurisdiction Type
Federal Question
Cause of Action
35:271 Patent Infringement
Jury Demand
None
Parties
Defendant
Plaintiff
Novartis Pharmaceuticals Corporation
Represented By
2 Attorneys ListedMcCarter & English, LLP
Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Tel: +1 (302) 984-6300
Fax: +1 (302) 984-6399
Renaissance Centre, 405 N. King Street, 8th Floor
Novartis AG
Represented By
2 Attorneys ListedMcCarter & English, LLP
Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Tel: +1 (302) 984-6300
Fax: +1 (302) 984-6399
Renaissance Centre, 405 N. King Street, 8th Floor
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Leonard P. Stark
Docket Entries
COMPLAINT filed against Glenmark Generics Inc., Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400.00, receipt number 0311-1536812.) - filed by Novartis Pharmaceuticals Corporation, Novartis AG. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Civil Cover Sheet)(snb) (Entered: 06/19/2014)
2014-06-18
1
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (snb, ) (Entered: 06/19/2014)
2014-06-18
1
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 5/12/14. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 11/12/2016. (snb) (Entered: 06/19/2014)
2014-06-18
1
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,025,391; 6,172,107; 6,306,900. (snb, ) (Entered: 06/19/2014)
2014-06-18
1